These findings are consistent with the results previously reported by our research group, where the distinction between B-ALL subtypes based on CD34 expression has been closely associated with a substantial and functional reduction in the percentage of normal B-cell progenitors and precursors (43). This evidence concerns the gene CD34 and acute lymphoblastic leukemia.